Gene expression profiling in fetal, aged, and Alzheimer hippocampus: A continuum of stress-related signaling

Neurochemical Research

Volumn 29, Issue 6, 2004, Pages 1287-1297

  Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Angiogenesis; Brain transcription; Cellular phospholipase A2; Hippocampus; Neuroinflammation; Pentraxin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA CHEMOKINE; CYCLOOXYGENASE 2; DAXX PROTEIN; FAS ANTIGEN; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; PENTRAXIN; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; RNA; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; PRIMER DNA;

AGING; ALZHEIMER DISEASE; ANGIOGENESIS; APOPTOSIS; CORRELATION ANALYSIS; GENE EXPRESSION PROFILING; GENETIC CODE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INFLAMMATION; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STRESS; UPREGULATION; ADULT; AGED; ARTICLE; DNA MICROARRAY; FETUS; GENETIC TRANSCRIPTION; GENETICS; MENTAL STRESS; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION;

ADULT; AGED; ALZHEIMER DISEASE; BASE SEQUENCE; DNA PRIMERS; FETUS; GENE EXPRESSION PROFILING; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC;

EID: 3142718813     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000023615.89699.63     Document Type: Review

References (63)

1. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., and Murtagh, F. R. 1995. An English translation of Alzheimer's 1907 paper, "Über elne eigenartige Erkankung der Hirnrinde" Clin. Anat. 8:429-431.
2. Butterfield, D. A., Drake, J., Pocernich, C., and Castegna, A. 2001. Evidence of oxidative damage in Alzheimer's disease brain: central role tor amyloid beta-peptide. Trends Mol. Med. 7: 548-554.
3. Sleegers, K. and Van Duijn, C. M. 2001. Alzheimer's disease: genes, pathogenesis and risk prediction. Community Genet. 4:197-203.
4. McGeer, P. L. and McGeer, E. G. 2001. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Interleukin-I and the Immunogeneties of Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:471-476.
5. McGeer, P. L. and McGeer, E. G. 2001. Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22:799-809.
6. Shastry, B. S. 2001. Molecular and cell biological aspects of Alzheimer disease. J. Hum. Genet. 46:609-618.
7. Selkoe, D. J. 2002. Alzheimer's disease is a synaptic failure. Science 298:789-791.
8. Rocchi, A., Pellegrini, S., Siciliano, G., and Murri, L. 2003. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res. Bull. 61:1-24.
9. Lukiw, W. J. 2001. Aluminum and gene transcription in the mammalian central nervous system. Pages 147-168, in Exley, C. (ed.), Aluminum and Alzheimer's disease, the science that describes the link, Elsevier Press, New York.
10. Lukiw, W. J., Rogaev, E. I., and Bazan, N. G. 1996. Synaptic and cytoskeletal RNA message levels in sporadic Alzheimer neocortex. Alzheimer's Research 2:221-227.
11. Lukiw, W. J., Carver, L. A., LeBlanc, H. J., and Bazan, N. G. 2000. Analysis of 1184 gene transcript levels in AD CA1 hippocampus: synaptic signaling and transcription factor deficits and upregulation of pro-inflammatory pathways. Alzheimer's Reports 3:161-167.
12. Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., and Somogyi, R. 2001. Gene expression profile of Alzheimer's disease. DNA and Cell Biology 20:683-695.
13. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., and Lukiw, W. J. 2002. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70: 462-473.
14. Tsuji, T., Shiozaki, A., Kohno, R., Yoshizato, K., and Shimohama, S. 2002. Proteomic profiling and neurodegeneration in Alzheimer's disease. Neurochem. Res. 27:1245-1253.
15. Rogaev, E. I., Sherrington, R., Wu, C., Levesque, G., Liang, Y., Rogaeva, E. A., Ikeda, M., Holman, K., Lin, C., Lukiw, W. J., de Jong, P. J., Fraser, P. E., Rommens, J. M., and St. George-Hyslop, P. 1997. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomic 40: 415-424.
16. Tarkowski, E., Issa, R., Sjogren, M., Wallin, A., Blennow, K., Tarkowski, A., and Kumar, P. 2002. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging 23:237-243.
17. Mufson, E. J., Counts, S. E., and Ginsberg, S. D. 2002. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem. Res. 27:1035-1048.
18. Martin, L. J. 2001. Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med. 7:455-478.
19. Heyman, A., Fillenbaum, G. G., Welsh-Bohmer, K. A., Gearing, M., Mirra, S. S., Mohs, R. C., Peterson, B. L., and Pieper, C. F. 1998. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 51:159-162.
20. Newell, K. L., Hyman, B. T., Growdon, J. H., and Hedley-Whyte. E. T. 1999. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheinier disease. J. Neuropathol. Exp. Neurol. 58: 1147-1155.
21. Morris, J. C., and Price, J. L. 2001. Pathological correlates of nondemented aging, mild cognitive impairment and early stage Alzheimer's disease. J. Molec. Neuroscience 17:101-118.
22. Kaufmann, W. A., Barnas, U., Humpel, C., Nowakowski, K., DeCol, C., Gurka, P., Ransmayr, G., Hinterhuber, H., Winkler, H., and Marksteiner. J. 1998. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease. Eur. J. Neurosci. 10:1084-1094.
23. Knil, J. J., Patel, S., Harding, A. J., and Halliday, G. M. 2002. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol. (Berl) 103:370-306.
24. Bazan, N. G. and Lukiw, W. J. 2002. COX-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J. Biol. Chem. 277:30359-67.
25. Rossier, M., Zarski, R., Bohl, J., and Ohm, T. G. 2002. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol. (Berl) 103: 363-369.
26. Fu, L., Abu-Khali, J. A., Morrison, R. S., Geschwind, D. H., and Kornblum, H. I. 2003. Expression patterns of epidermal growth factor receptor and fibroblast growth factor receptor 1 mRNA in fetal human brain. J. Comp. Neurol. 462:265-73.
27. Takahashi, Y. 1992. Gene expression in cells of the central nervous system. Prog. Neurobiol. 38:523-569.
28. Bernaudin, M., Nouvelot, A., MacKenzie, E. T., and Petit, E. 1998. Selective neuronal vulnerability and specific glial reactions in hippocampal and neocortical organotypic cultures submitted to ischemia. Exp. Neurol. 150:30-39.
29. Wheal, H. V., Chen, Y., Mitchell, J., Schachner, M., Maerz, W., Wieland, H., Van Ressum, D., and Kirseh, J. 1998. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Prog. Neurobiol. 55:611-640.
30. Kingsbury, A. E., Foster, O. J., Nisbet, A. P., Cairns, N., Bray, L., Eve, D. J., Lees, A. J., and Marsden, C. D. 1995. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol. Brain Res. 28:311-318.
31. Ross, J. 1996. Control of messenger RNA stability in higher eukaryotes. Trends Genet. 5:171-175.
32. Guhaniyogi, J. and Brewer, G. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
33. Liu, L. X., Lu, H., Luo, Y., Date, T., Belanger, A. J., Vincent, K. A., Akita, G. Y., Goldberg, M., Cheng, S. H., Gregory, R. J., and Jiang, C. 2002. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor I. Biochem. Biophys. Res. Commun. 291:908-914.
34. Thomas, E. A., Alvarez, C. E., and Sutcliffe, J. G. 2000. Evolutionary distinct classes of S27 ribosomal proteins with differential mRNA expression in rat hypothalamus. J. Neurochem. 74:2259-2267.
35. Sutcliffe, J. G. 2001. Open-system approaches to gene expression in the CNS. J. Neurosci. 21:8306-8309.
36. Venter, J. C., Adams, M. D., and Meyers, E. W., et al. 2001. The sequence of the human genome. Science 291:1304-51.
37. Ho, L., Pieroni, C., Winger, D., Purohit, D. P., Aisen, P. S., and Pasinetti, G. M. 1999. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res. 57:295-303.
38. Kitamura, Y., Shimohama, S., Koike, H., Kakimura, J., Matsuoka, Y., Nomura, Y., Gobieke-Haerter, P. J., and Taniguchi, T. 1999. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 254:582-586.
39. Mrak, R. E. and Griffin, W. S. 2000. Interleukin-1 and the immunogenetics of Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:471-476.
40. Franceschi, C., Valensin, S., Lescal, F., Olivieri, F., Licastro, F., Grimaldi, L. M., Monti, D., De Benedictis, G., and Bonafe, M. 2001. Neuroinflamrtiation and the genetics of Alzheimer's disease: the search for a proinflammatory phenotype. Aging 13: 163-170.
41. Sayre, L. M., Smith, M. A., and Perry, G. 2001. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8:721-738.
42. Rogers, J. 1995. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneimittelforschung 45:439-442.
43. Tol, J., Roks, G., Slooter, A. J., and van Duijn, C. M. 1999. Genetic and environmental factors in Alzheimer's disease. Rev. Neurol. 155:10-16.
44. Rogan, S. and Lippa, C. F. 2002. Alzheimer's disease and other dementias: a review. American Journal of Alzheimer's Disease and Other Dementias 17:11-17.
45. Bazan, N. G., Colangelo, V., and Lukiw, W. J. 2002. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 68-69:197-210.
46. Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., and Bazan N. G. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278: 43807-43817.
47. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. 1997. DAXX, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067-1076.
48. Martin, L. J. 2001. Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med. 7:455-478.
49. Christians, E. S., Yan, L. J., and Benjamin, I. J. 2002. Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit. Care Med. 30 (1 Suppl):S43-50.
50. Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P., and Xu, H. 2003. Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. USA 100:721-726.
51. Kalaria, R. N., Cohen, D. L., Premkumar, D. R., Nag, S., LaManna, J. C., and Lust, W. D. 1998. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res. Mol. Brain Res. 62:101-5.
52. Vagnucci, A. H. Jr., and Li, W. W. 2003. Alzheimer's disease and anglogenesis. Lancet 361:605-608.
53. Wang, Y., Cui, H., Schroering, A., Ding, J. L., Lane, W. S., McGill, G., Fisher, D. E., and Ding, H. F. 2002. NF-kappa B p100 is a pro-apoptotic protein with anti-oncogenic function. Nat. Cell Biol. 4:888-893.
54. Price, D. L., Tanzi, R. E., Borchelt, D. R., and Sisodia S. S. 1998. Alzheimer's disease: genetic studies and transgenic models. Ann. Rev. Genet. 32:461-493.
55. Ge, Y. W., and Lahiri, D. K. 2002. Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann. N. Y. Acad. Sci. 973: 463-467.
56. Lahiri, D. K., Chen, D., Vivien, D., Ge, Y. W., Greig, N. H., and Rogers, J. T. 2003. Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5′-UTR-binding nuclear factor and its implications in Alzheimer's disease. J. Alzheimer's Dis. 5:81-90.
57. Kaltschmidt, B., Linker, R. A., Deng, J., and Kaltschmidt, C. 2002. Cyclooxygenase-2 is a neuronal target gene of NF-kappaB. BMC Mol. Biol. 3:1-12.
58. Mattson, M. P., Culmsee, C., Yu, Z., and Camandola, S. 2000. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74:443-456.
59. Gewurz, H., Zhang, X. H., and Lint, T. F. 1995. Structure and function of the pentraxins. Curr. Opin. Immunol. 7:54-64.
60. Salazar, A., Pinto, X., and Mana, J. 2001. Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders. Eur. J. Clin Invest. 31:1070-1077.
61. de la Torre, J. C. 2002. Vascular basis of Alzheimer's pathogenesis. Ann. NY Acad. Sci. 977:196-215.
62. Hromas, R., Gray, P. W., Chantry, D., Godiska, R., Krathwohl, M., Fife, K., Bell, G. I., Takeda, J., Aronica, S., Gordon, M., Cooper, S., Broxmeyer, H. E., and Klemaz, M. J. 1997. Cloning and characterization of exodus, a novel beta-chemokine. Blood 89:3315-3322.
63. Lukiw, W. J., Rogaev, E. I., and Bazan, N. G. 2001. Potential of transcriptional coordination of nine genes associated with Alzheimer's disease. Alzheimer's Reports 3:233-245.